Guiding Principles for Assigning Auxiliary Labels for Outpatient Medications at BCCA. Methods. 1. BCCA pharmacy practice leaders and the medication safety pharmacist Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). WARNING. EMBRYO-FETAL TOXICITY, HEMATOLOGIC TOXICITY, and VENOUS and ARTERIAL THROMBOEMBOLISM. Embryo-Fetal Toxicity. Do not use REVLIMID during pregnancy. For etoposide, 50 to 100 mg/m2 IV daily for 5 days or 100 mg/m2 IV on days 1, 3, and 5 in combination with other approved chemotherapeutic agents. Doxorubicin (DXR) is a 14-hydroxylated version of daunorubicin, the immediate precursor of DXR in its biosynthetic pathway. Daunorubicin is more abundantly found as a natural product because it is produced by a number of different wild type strains of Streptomyces. Docetaxel, sold under the brand name Taxotere, treats cancers of the breast, lung, prostate, stomach, head and neck. It is one of the most popular drugs doctors use to treat breast cancer, and studies show it extends survival and stops tumors from spreading. full prescribing information warning: fatal infusion reactions, tumor lysis syndrome (tls), severe mucocutaneous reactions, and progressive multifocal leukoencephalopathy (pml) 0.8 mg/kg IV over 2 hours every 6 hours for 16 doses starting on day -7 of transplantation in combination with cyclophosphamide 60 mg/kg IV over 1 hour on day -3 and -2 (beginning no sooner than 6 hours after the last busulfan dose). WARNING. SERIOUS INFECTIONS and MALIGNANCIES. Serious Infections. Patients treated with Enbrel are at increased risk for developing serious infections that may lead to hospitalization or death [see WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS]. Number: 0314. Policy. Note: This note applies to the use or rituximab for rheumatoid arthritis: There are several brands of targeted immune modulators on the market.